Welcome to OrbiMed! We encourage biotechnology, pharmaceutical and medical device companies worldwide to contact us.

For publicly-traded companies:

Whenever possible, we seek to be a long-term, value-added, strategic investor. We prefer to make significant investments with a time horizon spanning several years or more.

If your firm is a publicly-traded health sciences company and you would like to arrange a meeting with our team, please send us a description of your firm and desired meeting time by email or call Melanie Wong at (212) 739-6400.

For privately-held companies:

We have been investors in venture capital health sciences companies since 1993. Our venture capital strategy is focused on drug development, drug discovery and medical device companies. We are active at all stages of development, with a particular emphasis on mid-stage private companies. Our typical investment size ranges from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role in helping management to achieve strategic, financial and operational objectives via participation at the Board of Directors level. OrbiMed professionals currently serve on the Board of Directors of dozens of different life sciences companies.

If your firm is a privately-held health sciences company and you would like to arrange a meeting with our team, please send us a description of your firm and desired meeting time by email or call Chau Khuong at (212) 739-6400.

For venture capital opportunities pertaining to Asia, please contact Jonathan Wang by email or phone at (212) 739-6400.

Please also browse some of our private equity investments.

For general inquiries:

Please contact us by phone at (212) 739-6400.

Office Address:

767 Third Avenue
30th Floor
New York, NY 10017

Click for directions.